Watch Immuron Ltd CEO Steve Lydeamore Present At JustStocks ‘Stars in 2024’ Investor Event

Chief Executive Officer Steve Lydeamore presented at JustStocks ‘Stars in 2024.’ Immuron is an integrated biopharmaceutical company focused on developing, and commercialising, oral therapeutics for the treatment of gut-mediated diseases.

Articles of Interest